Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases

Recruiting now

Conditions studied: Acute Kidney Injury, Chronic Kidney Diseases, Solid-organ Transplantation, Cancer, Metabolic Disease, Immune Diseases

In brief

Managing patients with renal failure requires an understanding of the molecular mechanisms that lead to its occurrence (i.e. upstream of the disease), its worsening and its persistence (i.e. downstream), while also specifying the risk of worsening renal failure (risk stratification, intolerance to the treatment or complications (infectious, metabolic, cardiovascular, cancer…). Nephrogene 2.0 aims to study these different components of kidney, immune and solid organ transplantation (SOT)-related diseases.

Key facts

Study ID

NCT05318196

Run by

University Hospital, Toulouse

People needed

5000

Starts

2022-09-05

Expected to finish

2032-09-01

Last updated by the study team

2026-03-19

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients (> 18 year of age) with kidney disease or at risk to develop a kidney disease,
• Patients followed by a practitioner of the Department of Nephrology and Organ Transplantations of the University Hospital of Toulouse (France)

You may not qualify if…

• consent deny
• inability of the patient or its family to give consent.

Where it is running

• Rangueil University Hospital — Toulouse, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.